GCK inhibition as a new therapeutical approach in RASMut myeloma and possible strategy to overcome therapy resistance

Speaker(s)

• 

  Josefine Krüger, MD

  Postdoctoral Research Fellow
  Columbia University Irving Medical Center
  New York, New York